“…Isolation of norjuziphine.-Elution of column B with CHCl3-MeOH (95:5) gave a residue (100 mg) that was rechromatographed over silicic acid (20 g). Elution of this column with CHCl3-MeOH (98:2) afforded a colorless residue (35 mg) which on treatment with MeOH gave norjuziphine (20 mg) as colorless crystals, Rf0.34, mp 155-157°(MeOH), [cxJ23d + 12°(c 0.43, MeOH); uv, max (MeOH) 284 nm (sh) (log 3.22), 280(3.26) and 234(3.52); cd, [ ]288 +2,280. 36); ir, v max (KBr) 3260 cm-3010, 2930, 2830, 1612, 1590, 1515, 1490, 1435, 1380, 1340, 1240, 1170, 1160, 1100, 1045, 995, 955, 920, 850, 838, 805, 795, 788, and 750; pmr (MeOH-d4 + TMS), 3.82 (s, 3H, OCH3), 6.53 (d, 2H, J=8Hz, ArH), 6.72 (d, 1H, J=8Hz, ArH), 6.79 (d, lH,/=8Hz, ArH), and 7.09 (d, 2H,/=8Hz, ArH); ms, mlz 285 (<1%)(M+), 178(100), 163 (33) and 107 (10). The structure was confirmed via the preparation of the methiodide salt by the treatment of norjuziphine (15 mg) in Me2CO (10 ml) with methyl iodide (0.5 ml) under reflux fot 48 h. Evaporation of the solvent yielded a residue whose ir spectrum was identical with authentic 2-methyl-7-methoxy-8,4'-dihydroxy-l-benzyl-l,2,3,4-tetrahydroisoquinoline methiodide (oblongine methiodide) (38).…”